These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7685403)

  • 1. Gene mapping and expression of two immunodominant Epstein-Barr virus capsid proteins.
    van Grunsven WM; van Heerde EC; de Haard HJ; Spaan WJ; Middeldorp JM
    J Virol; 1993 Jul; 67(7):3908-16. PubMed ID: 7685403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Epstein-Barr virus scaffold (BdRF1/VCA-p40) and small capsid protein (BFRF3/VCA-p18) into a single molecule for improved serodiagnosis of acute and malignant EBV-driven disease.
    Fachiroh J; Stevens SJ; Haryana SM; Middeldorp JM
    J Virol Methods; 2010 Oct; 169(1):79-86. PubMed ID: 20621126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization and diagnostic application of immunodominant domains of the BFRF3-encoded Epstein-Barr virus capsid protein.
    van Grunsven WM; Spaan WJ; Middeldorp JM
    J Infect Dis; 1994 Jul; 170(1):13-9. PubMed ID: 8014488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and molecular characterization of two diagnostically relevant marker proteins of the Epstein-Barr virus capsid antigen complex.
    van Grunsven WM; Nabbe A; Middeldorp JM
    J Med Virol; 1993 Jun; 40(2):161-9. PubMed ID: 8395556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of VCA (viral capsid antigen) and EBNA1 (Epstein-Barr-virus-encoded nuclear antigen 1) genes of Epstein-Barr virus in Pichia pastoris and application of the products in a screening test for patients with nasopharyngeal carcinoma.
    Hu B; Hong G; Li Z; Xu J; Zhu Z; Li L
    Biotechnol Appl Biochem; 2007 May; 47(Pt 1):59-69. PubMed ID: 17129209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen.
    Lin SF; Sun R; Heston L; Gradoville L; Shedd D; Haglund K; Rigsby M; Miller G
    J Virol; 1997 Apr; 71(4):3069-76. PubMed ID: 9060668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two 21-kilodalton components of the Epstein-Barr virus capsid antigen complex and their relationship to ZEBRA-associated protein p21 (ZAP21).
    Serio TR; Angeloni A; Kolman JL; Gradoville L; Sun R; Katz DA; Van Grunsven W; Middeldorp J; Miller G
    J Virol; 1996 Nov; 70(11):8047-54. PubMed ID: 8892929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of human serum antibodies to the BFRF3 Epstein-Barr virus capsid component by means of a DNA-binding assay.
    Shedd D; Angeloni A; Niederman J; Miller G
    J Infect Dis; 1995 Nov; 172(5):1367-70. PubMed ID: 7594680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
    Fachiroh J; Paramita DK; Hariwiyanto B; Harijadi A; Dahlia HL; Indrasari SR; Kusumo H; Zeng YS; Schouten T; Mubarika S; Middeldorp JM
    J Clin Microbiol; 2006 Apr; 44(4):1459-67. PubMed ID: 16597877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological diagnosis of Epstein-Barr virus infection by novel ELISAs based on recombinant capsid antigens p23 and p18.
    Färber I; Hinderer W; Rothe M; Lang D; Sonneborn HH; Wutzler P
    J Med Virol; 2001 Apr; 63(4):271-6. PubMed ID: 11241457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus (P3HR-1) defective DNA codes for components of both the early antigen and viral capsid antigen complexes.
    Cho MS; Gissmann L; Hayward SD
    Virology; 1984 Aug; 137(1):9-19. PubMed ID: 6089423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serodiagnosis of Epstein-Barr virus infection by using recombinant viral capsid antigen fragments and autologous gene fusion.
    Hinderer W; Lang D; Rothe M; Vornhagen R; Sonneborn HH; Wolf H
    J Clin Microbiol; 1999 Oct; 37(10):3239-44. PubMed ID: 10488185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion bodies of recombinant Epstein-Barr virus capsid antigen p18 as potential immobilized antigens in enzyme immunoassays for detection of nasopharyngeal carcinoma.
    Lim CS; Goh SL; Kariapper L; Krishnan G; Lim YY; Ng CC
    Clin Chim Acta; 2015 Aug; 448():206-10. PubMed ID: 26164385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of rabbit antibodies against the viral capsid antigen (VCA) of the Epstein-Barr virus (EBV).
    Vestergaard BF; Hesse J; Norrild B; Klein G
    Int J Cancer; 1978 Mar; 21(3):323-8. PubMed ID: 75856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and characterization of cDNA clones corresponding to transcripts from the BamHI G region of the Epstein-Barr virus genome and expression of BGLF2.
    Chen MR; Hsu TY; Lin SW; Chen JY; Yang CS
    J Gen Virol; 1991 Dec; 72 ( Pt 12)():3047-55. PubMed ID: 1662696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
    Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
    Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex.
    Pearson GR; Luka J; Petti L; Sample J; Birkenbach M; Braun D; Kieff E
    Virology; 1987 Sep; 160(1):151-61. PubMed ID: 2820125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved accuracy of detection of nasopharyngeal carcinoma by combined application of circulating Epstein-Barr virus DNA and anti-Epstein-Barr viral capsid antigen IgA antibody.
    Leung SF; Tam JS; Chan AT; Zee B; Chan LY; Huang DP; Van Hasselt A; Johnson PJ; Lo YM
    Clin Chem; 2004 Feb; 50(2):339-45. PubMed ID: 14684618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning and expression of two human recombinant monoclonal Fab fragments specific for EBV viral capsid antigen.
    Dong L; Masaki Y; Takegami T; Kawanami T; Itoh K; Jin ZX; Huang CR; Tong XP; Fukushima T; Tanaka M; Sawaki T; Sakai T; Sugai S; Okazaki T; Hirose Y; Umehara H
    Int Immunol; 2007 Mar; 19(3):331-6. PubMed ID: 17272286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Six anti-Epstein-Barr virus antibodies in healthy adults in a high risk area of nasopharyngeal carcinoma].
    Yi B; Gu YL; Zong YS; Cheng WM; Ji MF
    Ai Zheng; 2009 Aug; 28(8):822-6. PubMed ID: 19664327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.